index - Epidemiology in dermatology and evaluation of therapeutics

DOCUMENTS

95

 

NOTICES

Chargement de la page

 

 

MOTS CLES

Antimicrobial Stewardship Antimicrobiens Alcohol Sacroiliitis Epidemiology Prostate cancer ArtThese Pharmacoepidemiology Adolescent Biologic Psoriasis Apre-milast Biological therapy Bacterial Cardio-oncology Auto-immune hepatitis Quality of life Cardiomyopathy Anticancer drugs Sipuleucel-T Antibiotics Infliximab Dermatology Biologic therapy Antimicrobial resistance Stability Biomarkers Autoimmune diseases Amyloidosis Management Pregnancy Angiotensin receptor blockers Access to care COVID-19 Accelerometer Atrial fibrillation Anti-TNF Beta-lactam antibiotics Spondylitis Antimicrobials Intensive care Vigibase® Axial spondyloarthritis Adverse side effects Cardiotoxicity Immune checkpoint inhibitors Autoimmunity Aging Pharmaco-Épidémiologie Anxiety Ankylosing Antibiotic resistance Biologics Network meta-analysis Biological Therapy ASDAS Apremilast Treatment Atopic dermatitis Addiction Spondyloarthritis Ustekinumab Graft-versus-host disease Drug reaction Endocrine toxicity Albinism Arthritis Bacterial rhinosinusitis Azathioprine Etanercept Systematic review Immune-related adverse events Adalimumab Angiotensin-converting enzyme inhibitors Biosimilar Pharmaceuticals Psoriatic arthritis Abus d'antibiotiques Pharmacovigilance Antibiotic misuse Meta-Analysis Immunotherapy Anti-Bacterial Agents Primary adrenal insufficiency Glucocorticoids Drug survival Cancer Alitretinoin Arrhythmia Placebo Acute Myeloid Leukaemia AML Burden Auto-Diagnostic Ankylosing spondylitis Biomédicaments Biologic drug Anti-HCV Direct Acting Antivirals DAA Ethics Méta-Analyse BTK protein Anxiété

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS